Explainable AI for Cancer Drug Response Prediction: Beyond Univariate Feature Attributions

• URL: http://arxiv.org/abs/2607.00931v1
• Date: Wed, 01 Jul 2026 13:34:04 GMT
• Title: Explainable AI for Cancer Drug Response Prediction: Beyond Univariate Feature Attributions
• Abstract summary: We present ILLUME+, a scalable post-hoc explainability framework that moves beyond single-gene assessments to capture multiple forms of explanation.<n>ILLUME+ produces more stable gene importance scores than existing baselines, recovers established drug-gene associations and mechanisms of action, and enables AI-assisted hypothesis generation to uncover novel interaction-driven molecular signals in cancer biology.
• Score: 4.432106960947219
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Predicting cancer drug response from transcriptomic profiles is a cornerstone of precision oncology, yet the scientific value of machine learning models hinges not solely on predictive accuracy, but also on their capacity to generate reliable biological insights. Current explainability approaches in this setting are computationally costly, lack robustness, and reduce complex drug response to univariate gene importance scores, overlooking the coordinated gene activity that drives sensitivity and resistance. In this work, we present ILLUME+, a scalable post-hoc explainability framework that moves beyond single-gene assessments to capture multiple, complementary forms of explanation. Integrated into our end-to-end pipeline, ILLUME+ produces more stable gene importance scores than existing baselines, recovers established drug-gene associations and mechanisms of action, and enables AI-assisted hypothesis generation to uncover novel interaction-driven molecular signals in cancer biology.

Related papers

• BioM-JEPA: joint-embedding prediction of graph-connected gene blocks in single cells [64.21963170814706]
  BioM-JEPA predicts aggregate representations of graph-connected gene blocks.<n>A student network infers each target-block representation from the remaining genes in a cell.<n>Across CellBench tasks, BioM-JEPA embeddings retained expression, pathway and neighbourhood information.
  arXiv  Detail & Related papers  (2026-08-06T11:58:29Z)
• Genotype-Conditioned Molecular Generation via Evidence-Grounded Multi-Objective Latent Perturbation in Diffusion Models [28.58133087329719]
  Generative models conditioned on cancer genotypes offer a promising avenue for personalized drug discovery.<n>We present a latent-space optimization approach for a pretrained genotype-to-drug diffusion model.<n>We show consistent and noticeable improvements over competing baselines in sensitivity, drug-likeness, synthesizability, and chemical validity.
  arXiv  Detail & Related papers  (2026-05-31T21:43:11Z)
• Plausibility Is Not Prediction: Contrastive Evidence for LLM-Based Cellular Perturbation Reasoning [27.902219493068824]
  Perturbation experiments are central to understanding cellular mechanisms.<n>They remain costly and sparse, motivating prediction of gene expression responses for unobserved conditions.<n>We introduce CORE, which reframes prediction as a comparison task by organizing evidence into positive and negative outcomes from related perturbations.
  arXiv  Detail & Related papers  (2026-05-31T06:13:26Z)
• Contextual Invertible World Models: A Neuro-Symbolic Agentic Framework for Colorectal Cancer Drug Response [4.796382757669091]
  Precision oncology is currently limited by the small-N, large-P paradox.<n>We present a Neuro-Symbolic Agentic Framework that bridges this gap.<n>Our framework provides a transparent, biologically grounded path towards explainable AI in cancer research.
  arXiv  Detail & Related papers  (2026-03-01T16:15:58Z)
• Progressive Multi-Agent Reasoning for Biological Perturbation Prediction [32.71169480836875]
  We present LINCSQA, a novel benchmark for predicting target gene regulation under complex chemical perturbations.<n>We also propose PBio-Agent, a multi-agent framework that integrates difficulty-aware task sequencing with iterative knowledge refinement.<n>Our key insight is that genes affected by the same perturbation share causal structure, allowing confidently predicted genes to contextualize more challenging cases.
  arXiv  Detail & Related papers  (2026-02-07T06:59:44Z)
• R-GenIMA: Integrating Neuroimaging and Genetics with Interpretable Multimodal AI for Alzheimer's Disease Progression [63.97617759805451]
  Early detection of Alzheimer's disease requires models capable of integrating macro-scale neuroanatomical alterations with micro-scale genetic susceptibility.<n>We introduce R-GenIMA, an interpretable multimodal large language model that couples a novel ROI-wise vision transformer with genetic prompting.<n>R-GenIMA achieves state-of-the-art performance in four-way classification across normal cognition, subjective memory concerns, mild cognitive impairment, and AD.
  arXiv  Detail & Related papers  (2025-12-22T02:54:10Z)
• GENERator: A Long-Context Generative Genomic Foundation Model [66.46537421135996]
  We present GENERator, a generative genomic foundation model featuring a context length of 98k base pairs (bp) and 1.2B parameters.<n>Trained on an expansive dataset comprising 386B bp of DNA, the GENERator demonstrates state-of-the-art performance across both established and newly proposed benchmarks.<n>It also shows significant promise in sequence optimization, particularly through the prompt-responsive generation of enhancer sequences with specific activity profiles.
  arXiv  Detail & Related papers  (2025-02-11T05:39:49Z)
• Binding Affinity Prediction: From Conventional to Machine Learning-Based Approaches [48.66541987908136]
  Much work has been devoted to predicting binding affinity over the past decades.<n>We note growing use of both traditional machine learning and deep learning models for predicting binding affinity.<n>With improved predictive performance and the FDA's phasing out of animal testing, AI-driven in silico models, such as AI virtual cells (AIVCs), are poised to advance binding affinity prediction.
  arXiv  Detail & Related papers  (2024-09-30T03:40:49Z)
• Variational and Explanatory Neural Networks for Encoding Cancer Profiles and Predicting Drug Responses [40.80133767939435]
  Existing AI models face challenges due to noise in transcriptomics data and lack of biological interpretability. We introduce VETE, a novel neural network framework that incorporates a variational component to mitigate noise effects. VETE bridges the gap between AI-driven predictions and biologically meaningful insights in cancer research.
  arXiv  Detail & Related papers  (2024-07-05T13:13:02Z)
• Single-Cell Deep Clustering Method Assisted by Exogenous Gene Information: A Novel Approach to Identifying Cell Types [50.55583697209676]
  We develop an attention-enhanced graph autoencoder, which is designed to efficiently capture the topological features between cells. During the clustering process, we integrated both sets of information and reconstructed the features of both cells and genes to generate a discriminative representation. This research offers enhanced insights into the characteristics and distribution of cells, thereby laying the groundwork for early diagnosis and treatment of diseases.
  arXiv  Detail & Related papers  (2023-11-28T09:14:55Z)
• Causal machine learning for single-cell genomics [94.28105176231739]
  We discuss the application of machine learning techniques to single-cell genomics and their challenges. We first present the model that underlies most of current causal approaches to single-cell biology. We then identify open problems in the application of causal approaches to single-cell data.
  arXiv  Detail & Related papers  (2023-10-23T13:35:24Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.